Log in to save to my catalogue

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2151198839

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

About this item

Full title

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

Publisher

London: Nature Publishing Group UK

Journal title

Nature nanotechnology, 2018-12, Vol.13 (12), p.1174-1181

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Pfs25 is a malaria transmission-blocking vaccine antigen candidate, but its apparently limited immunogenicity in humans has hindered clinical development. Here, we show that recombinant, polyhistidine-tagged (his-tagged) Pfs25 can be mixed at the time of immunization with pre-formed liposomes containing cobalt porphyrin–phospholipid, resulting in s...

Alternative Titles

Full title

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2151198839

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2151198839

Other Identifiers

ISSN

1748-3387

E-ISSN

1748-3395

DOI

10.1038/s41565-018-0271-3

How to access this item